Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.19% |
| 2 | Financials | 11.87% |
| 3 | Industrials | 10.26% |
| 4 | Energy | 9.33% |
| 5 | Technology | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDSO
1626
DELISTED
Medidata Solutions, Inc.
MDSO
| $3.13M | 0.01% |
63,052
+31,991
| +103% | +$1.66M |
|
1627
Veracyte
VCYT
$4.44B
| $3.13M | 0.01% |
404,127
+154,634
| +62% | +$1.16M |
|
|
INVN
1628
DELISTED
Invensense Inc
INVN
| $3.13M | 0.01% |
244,534
-64,571
| -21% | -$552K |
|
1629
Brookfield
BN
$104B
| $3.13M | 0.01% |
265,514
+22,335
| +9% | +$272K |
|
|
ARIA
1630
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.12M | 0.01% |
+250,925
| New | +$3.02M |
|
|
HTD
1631
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$920M
| $3.11M | 0.01% |
+134,811
| New | +$3.06M |
|
|
DYNC
1632
DELISTED
Vistra Energy Corp.
DYNC
| $3.11M | 0.01% |
50,000
| – | – |
|
|
INSY
1633
DELISTED
Insys Therapeutics, Inc.
INSY
| $3.1M | 0.01% |
337,217
+115,012
| +52% | +$1.3M |
|
|
FOMX
1634
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.1M | 0.01% |
279,391
+204,054
| +271% | +$1.92M |
|
1635
CALL
Neurocrine Biosciences
NBIX
$18.4B
| $3.1M | 0.01% |
80,000
+30,000
| +60% | +$1.36M |
|
1636
State Street SPDR S&P Regional Banking ETF
KRE
$4.55B
| $3.09M | 0.01% |
55,636
+38,325
| +221% | +$1.88M |
|
|
ORIT
1637
DELISTED
Oritani Financial Corp. New
ORIT
| $3.08M | 0.01% |
164,532
-204,381
| -55% | -$3.45M |
|
1638
MYR Group
MYRG
$5.31B
| $3.07M | 0.01% |
81,522
+36,548
| +81% | +$1.26M |
|
1639
Trane Technologies
TT
$104B
| $3.06M | 0.01% |
40,839
-402,162
| -91% | -$29M |
|
1640
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $3.05M | 0.01% |
63,711
-36,785
| -37% | -$1.78M |
|
1641
Amdocs
DOX
$5.83B
| $3.05M | 0.01% |
52,334
-668,499
| -93% | -$39.4M |
|
|
ONC
1642
BeOne Medicines Ltd
ONC
$34.3B
| $3.04M | 0.01% |
+100,229
| New | +$3.15M |
|
1643
Enel Chile
ENIC
$6.05B
| $3.02M | 0.01% |
664,274
+243,416
| +58% | +$1.17M |
|
1644
Civeo
CVEO
$376M
| $3.02M | 0.01% |
114,394
+24,375
| +27% | +$496K |
|
|
NP
1645
DELISTED
Neenah, Inc. Common Stock
NP
| $3.02M | 0.01% |
+35,396
| New | +$2.93M |
|
|
ISCA
1646
DELISTED
International Speedway Corp
ISCA
| $3.01M | 0.01% |
81,895
-5,174
| -6% | -$182K |
|
|
ELOS
1647
DELISTED
Syneron Medical Ltd
ELOS
| $3M | 0.01% |
357,523
+4,148
| +1% | +$32.5K |
|
1648
Citizens Financial Group
CFG
$30.8B
| $2.98M | 0.01% |
83,598
-2,327,658
| -97% | -$70.5M |
|
1649
New York Times
NYT
$12.2B
| $2.98M | 0.01% |
223,935
-289,453
| -56% | -$3.58M |
|
1650
PUT
Nucor
NUE
$60.5B
| $2.98M | 0.01% |
+50,000
| New | +$2.8M |
|
Similar funds
Millennium Management's Q4 2016 Portfolio in Review
As of Q4 2016, Millennium Management held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Millennium Management withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 10% a quarter earlier, followed by Financials and Industrials.
Against the trend, Millennium Management opened a new position in Target worth $175M.
- Millennium Management's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Millennium Management added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Millennium Management's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Millennium Management fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Millennium Management's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Millennium Management opened 858 new positions and closed 801 in Q4 2016.
- Millennium Management's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.